Skip to main content
. 2011 Jul 28;9:124. doi: 10.1186/1479-5876-9-124

Figure 2.

Figure 2

Dose escalation design. Three patients will be treated with the starting dose. If no DLT occurs, the next cohort will be treated with the next MAPC dose level. If one DLT occurs in a cohort, a second cohort of 3 patients will be treated with the same MAPC dose level. The study will be stopped if more than one DLT event is recorded after enrolling at most 6 patients.